Prognostic factors for classifying extranodal NK/T cell lymphoma, nasal type, as lymphoid neoplasia

European Journal of Haematology

Volumn 79, Issue 1, 2007, Pages 1-7

  Na, Im I ^a   Kang, Hye J ^a   Park, Yeon H ^a   Lee, Seung Sook ^a   Yoo, Hyung J ^a   Choe, Du H ^a   Ryoo, Baek Yeol ^a   Yang, Sung H ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

Lactate dehydrogenase; NK T cell lymphoma; Prognosis

Indexed keywords

LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; L-LACTATE DEHYDROGENASE; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NOSE NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME;

EID: 34347209976     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00876.x     Document Type: Article

References (28)

1. Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 1996 87 : 1207 10.
2. Siu LL, Chan JK, Kwong YL. Natural killer cell malignancies: clinicopathologic and molecular features. Histol Histopathol 2002 17 : 539 54.
3. Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006 24 : 612 8.
4. Ko YH, Kim CW, Park CS, Jang HK, Lee SS, Kim SH, Ree HJ, Lee JD, Kim SW, Huh JR. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 1998 83 : 806 12.
5. Kang YK, Kim B-S, Kim TW, et al. Clinicopathologic characteristics of Korean non-Hodgkin's lymphomas based on REAL classification. Cancer Res Treat 1999 31 : 641 52.
6. Chim CS, Ma SY, Au WY, Choy C, Lie AK, Liang R, Yau CC, Kwong YL. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004 103 : 216 21.
7. Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000 18 : 54 63.
8. Lee J, Park YH, Kim WS, et al. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 2005 41 : 1402 8.
9. Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997 89 : 4501 13.
10. Li YX, Yao B, Jin J, et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol 2006 24 : 181 9.
11. Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002 54 : 182 90.
12. Kwong YL, Chan AC, Liang RH. Natural killer cell lymphoma/leukemia: pathology and treatment. Hematol Oncol 1997 15 : 71 9.
13. Ooi GC, Chim CS, Liang R, Tsang KW, Kwong YL. Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity. AJR Am J Roentgenol 2000 174 : 1141 5.
14. Robbins KT, Fuller LM, Vlasak M, Osborne B, Jing BS, Velasquez WS, Sullivan JA. Primary lymphomas of the nasal cavity and paranasal sinuses. Cancer 1985 56 : 814 9.
15. Kim TM, Park YH, Lee SY, et al. Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type. Blood 2005 106 : 3785 90.
16. Wong KF, Chan JK, Ng CS, Lee KC, Tsang WY, Cheung MM. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol 1992 23 : 798 804.
17. Lee J, Kim WS, Park YH, et al. Nasal-type NK/T cell lymphoma: clinical features and treatment outcome. Br J Cancer 2005 92 : 1226 30.
18. Aviles A, Diaz NR, Neri N, Cleto S, Talavera A. Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. Clin Lab Haematol 2000 22 : 215 20.
19. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller- Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999 17 : 3835 49.
20. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, Ho FC. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996 20 : 103 11.
21. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999 17 : 1244.
22. Kwong YL, Chan AC, Liang R, Chiang AK, Chim CS, Chan TK, Todd D, Ho FC. CD56+ NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997 97 : 821 9.
23. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958 53 : 457 81.
24. Cox DR. Regression models and life-tables. J R Stat Soc 1972 34 : 187 220.
25. Pagano L, Gallamini A, Trape G, et al. NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey. Ann Oncol 2006 17 : 794 800.
26. Kim BS, Kim TY, Kim CW, Kim JY, Heo DS, Bang YJ, Kim NK. Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy-result of chemotherapy in NK/T-cell lymphoma. Acta Oncol 2003 42 : 779 83.
27. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993 329 : 987 94.
28. Au WY, Pang A, Choy C, Chim CS, Kwong YL. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 2004 104 : 243 9.